• No results found

Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment.

N/A
N/A
Info
Nedlasting
Protected

Academic year: 2022

Share "Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment."

Copied!
12
0
0

Laster.... (Se fulltekst nå)

Last ned nå ( 12 sider )

Fulltekst

Referanser

Last ned nå ( PDF - 12 sider - 1.60 MB )

RELATERTE DOKUMENTER

Predicting acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test

Background: The aim of this study was to search for predictors of acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder (ADHD),

ADHD, comorbid disorders and psychosocial functioning: How representative is a child cohort study? Findings from a national patient registry

ADHD: Attention deficit hyperactivity disorder; CAMHS: The Child and Adolescent Mental Health Services; CGAS: Children ’ s Global Assessment Scale; DSM-5: Diagnostic and

Association of Timing and Duration of Prenatal Analgesic Opioid Exposure with Attention-Deficit/Hyperactivity Disorder in Children

The aim of this study was to examine the association between timing and duration of prenatal analgesic opioid exposure and (1) ADHD diagnosis and/or filled prescription for

Convergent and discriminant validity pf psychiatric symptoms reported in The Norwegian Mother and Child Cohort Study at age 3 years with independent clinical assessment in the Longitudinal ADHD Cohort Study

The current study examines discriminant and convergent validity of parent questionnaires for symptoms of Attention Deficit Hyperactivity Disorder (ADHD), Oppositional

Teambasert og intensivert utredning av ADHD hos barn og unge – en forenklet kunnskapsoppsummering

ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention- deficit/hyperactivity disorder in children and adolescents.. An audit of an ADHD

University development and co-operation in Norway and Europe

In 1960, the Council of Europe took over responsibility for the work of the Universities Committee of the WEU and set up in its place a Com- mittee for Higher Education and

Attention-deficit/hyperactivity disorder; sex differences in psychiatric comorbidity and transgenerational recurrence risks : A population-based study using Norwegian registry data

Background Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous, multifactorial and life-spanning neurodevelopmental disorder for which the underlying

Co-occurring symptoms of attention deficit hyperactivity disorder (ADHD) in a population-based sample of adolescents screened for depression

We first present the frequency of ADHD symptoms, assessed by self reports on the adult ADHD Self-report Scale (ASRS) [38], in a sample defined as depressed according to their score